SkinBioTherapeutics PLC (AIM:SBTX, FRA:5KW)'s (AIM:SBTX, FRA:5KW) (LON:SBTX) Stuart Ashman talks to Proactive London about the plan for their psoriasis treatment ahead of their fourth quarter commercial launch.
He explains how the most recent findings have found that it can be used for other skin conditions such as treat eczema, acne and rosacea.
Ashman takes viewers through their comprehensive business update after a study in May showed a group of psoriasis sufferers using the cream found significant reductions in itchiness, redness, irritability and flakiness.